FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Nubratori Inc. | 71300-6591 | 71300-6591-1 | Lidocaine HCl and Bupivacaine HCl | Lidocaine HCl and Bupivacaine HCl | 3.75 mg/1 mL; 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Nubratori Inc. | 71300-6591 | 71300-6591-1 | Lidocaine HCl and Bupivacaine HCl | Lidocaine HCl and Bupivacaine HCl | 3.75 mg/1 mL; 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Nubratori Inc. | 028707055 | 71300-6591 | 71300-6591-1 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 3.75 mg/1 mL; 10 mg/1 mL | 2024-2 | valid | 2026-10-13 | |
| Nubratori Inc. | 71300-6591 | 71300-6591-1 | Lidocaine HCl and Bupivacaine HCl | Lidocaine HCl and Bupivacaine HCl | 3.75 mg/1 mL; 10 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Nubratori Inc. | 028707055 | 71300-6591 | 71300-6591-1 | Lidocaine Hydrochloride; Bupivacaine Hydrochloride | 10 mg/1 mL; 3.75 mg/1 mL | 2023-2 | valid | 2026-10-13 | |
| "Nubratori, Inc(028707055)" | 71300-6591 | 71300-6591-1 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 3.75 mg/1 mL; 10 mg/1 mL | 2023-1 | valid | 2026-10-13 | ||
| "Nubratori, Inc(028707055)" | 71300-6591 | 71300-6591-1 | Lidocaine Hydrochloride; Bupivacaine Hydrochloride | 20 mg/1 mL; 7.5 mg/1 mL | 2021-2 | valid | 2026-10-13 |